Chimerix (CMRX)
(Delayed Data from NSDQ)
$0.82 USD
-0.01 (-1.18%)
Updated Aug 9, 2024 03:59 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Brokerage Reports
Chimerix, Inc. [CMRX]
Reports for Purchase
Showing records 41 - 60 ( 116 total )
Company: Chimerix, Inc.
Industry: Medical - Products
ASCO 2022 Roundup for Covered Companies (Part 1)
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
HEALTHCARE- The Week Ahead in Life Sciences
Provider: Wedbush Securities Inc.
Analyst: Research Department
Company: Chimerix, Inc.
Industry: Medical - Products
1Q22 Results; Worldwide Rights to Tembexa Sold; DSTAT Development Discontinued
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
FY23 Congressional Justification for Health and Social Services Emergency Fund Out
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
4Q21 Results; BARDA Contract Could Be Announced Soon
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Data for ONC201 in Neuroendocrine Tumors Patients Published
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
BARDA Issues RFP to Chimerix for Smallpox Antiviral Tembexa
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Highlights From Non-Deal Roadshow; Raise PT to $24
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E